Evidence map›Paper›PMID 27469204›Full record

ArticleEuropean journal of immunology2016

Protein phosphatase 1 abrogates IRF7-mediated type I IFN response in antiviral immunity.

Ling Wang, Juan Zhao, Junping Ren, Kenton H Hall, Jonathan P Moorman, Zhi Q Yao, Shunbin Ning

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Reactivation of low avidity tumor-specific CD8Journal for immunotherapy of cancer · 2023
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Role of pyroptosis in inflammation and cancer.Cellular & molecular immunology · 2022
    Review
  14. Review
  15. Review
  16. Protein phosphatases in TLR signaling.Cell communication and signaling : CCS · 2021
    Review
  17. Review
  18. Review
  19. Duck Enteritis Virus VP16 Antagonizes IFN-Journal of immunology research · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ling WangCenter of Excellence for Inflammation, Infectious Diseases and Immunity, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
Juan ZhaoDepartment of Internal Medicine, East Tennessee State University, Quillen College of Medicine, Johnson City, TN, USA.
Junping RenCenter of Excellence for Inflammation, Infectious Diseases and Immunity, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
Kenton H HallDepartment of Internal Medicine, East Tennessee State University, Quillen College of Medicine, Johnson City, TN, USA.
Jonathan P MoormanCenter of Excellence for Inflammation, Infectious Diseases and Immunity, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
Zhi Q YaoCenter of Excellence for Inflammation, Infectious Diseases and Immunity, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
Shunbin NingCenter of Excellence for Inflammation, Infectious Diseases and Immunity, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA. nings1@etsu.edu.
East Tennessee State University · USJames H. Quillen VA Medical Center · US

Funding

miRNA-mediated premature T cell aging in vaccine failure during viral infectionR01AI114748 · NIAID · EAST TENNESSEE STATE UNIVERSITY · PI YAO, ZHI Q. · 2015 to 2019
$1.9M
Tim-3-mediated IL-12 dysregulation in antiviral responses to HCV infectionR01DK093526 · NIDDK · EAST TENNESSEE STATE UNIVERSITY · PI YAO, ZHI Q. · 2012 to 2015
$1.2M
NIAID NIH HHS R01 AI114748NIDDK NIH HHS R01 DK093526
6 · The paper itself

Abstract

Interferon (IFN) regulatory factor 7 (IRF7) plays a key role in the production of IFN-α in response to viral infection, and phosphorylation at IRF7 C-terminal serine sites is prelude to its function. However, phosphatases that negatively regulate IRF7 phosphorylation and activity have not been reported. In this study, we have identified a conserved protein phosphatase 1 (PP1)-binding motif in human and mouse IRF7 proteins, and shown that PP1 physically interacts with IRF7. Exogenous expression of PP1 subunits (PP1α, β, or γ) ablates IKKε-stimulated IRF7 phosphorylation and dramatically attenuates IRF7 transcriptional activity. Inhibition of PP1 activity significantly increases IRF7 phosphorylation and IRF7-mediated IFN-α production in response to Newcastle disease virus (NDV) infection or Toll-like receptor 7 (TLR7) challenge, leading to impaired viral replication. In addition, IFN treatment, TLR challenges and viral infection induce PP1 expression. Our findings disclose for the first time a pivotal role for PP1 in impeding IRF7-mediated IFN-α production in host immune responses.

Indexed as

Amino Acid MotifsAnimalsHEK293 CellsHumansImmunityInterferon-alphaInterferon Regulatory Factor-7MiceNewcastle DiseaseNewcastle disease virusPhosphorylationPromoter Regions, GeneticProtein BindingProtein Phosphatase 1RAW 264.7 CellsRNA, Small InterferingInterferon-alphaInterferon Regulatory Factor-7IRF7 protein, humanProtein Phosphatase 1RNA, Small InterferingIRF7PP1TLR7Type I IFN

Identifiers

PMID27469204
PMCPMC5175453
OpenAlexW2499609130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.